Terms Defined Elsewhere in this Agreement. As used in this Agreement, the following terms shall have the meanings ascribed to them in the sections indicated: AAA Section 13.13(a) Affiliate Agreement Default Section 2.14(c) Affiliate Agreement Default Notice Section 2.14(c) Affiliate Agreements Section 2.14(a) Agreement Preamble BIP Investor Member Preamble Blocker Seller Section 6.7 Board Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(e) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO Section 2.14(b) NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.1
Appears in 1 contract
Sources: Limited Liability Company Agreement (Nisource Inc.)
Terms Defined Elsewhere in this Agreement. As used in For purposes of this Agreement, the following terms shall have meanings set forth at the meanings ascribed to them in the sections indicatedsection of this Agreement indicated opposite such term: AAA “Agreement” Preamble “Allocation Schedule” Section 13.13(a3.21(a) Affiliate Agreement Default “Assets” Section 2.14(c3.13 “Balance Sheet Date” Section 3.05(a)(i) Affiliate Agreement Default Notice “Cashed Out Shares” Section 2.14(c2.06(c)(i) Affiliate Agreements “Certificate of Merger” Section 2.14(a2.01 “Closing” Section 2.02 “Closing Date” Section 2.02 “Collection Account” Recitals “Company” Preamble “Company Common Stock” Section 1.01 “Company Option” Section 2.09 “Company Registrations” Section 3.15(c) Agreement “Company Stockholder Consent” Recitals “Company Warrant” Section 2.10 “Confidential Information” Section 5.04 “Conflict” Section 3.02(d) “Consultant” Section 3.01(b) “Continuing Employee” Section 5.04(a)(i) “Current Consultant” Section 3.01(b) “Current Employee” Section 3.01(b) “Customer Contracts” Section 3.18(a) “D&O Tail” Section 5.06(c) “Deemed Common Stock Trust Common Unit” Section 2.06(c)(ii)(L) “Deemed Series A Trust Common Unit” Section 2.06(c)(ii)(I) “Deemed Series B Trust Common Unit” Section 2.06(c)(ii)(F) “Deemed Series C Prime Trust Common Unit” Section 2.06(c)(ii)(C) “Deemed Series C Trust Common Unit” Section 2.06(c)(ii)(E) “Deemed Series D Trust Common Unit” Section 2.06(c)(ii)(A) “Deemed Series Seed Prime Trust Common Unit” Section 2.06(c)(ii)(J) “Deemed Series Seed Trust Common Unit” Section 2.06(c)(ii)(K) “DGCL” Recitals “Dissenting Shares” Section 2.08 “E&O Tail” Section 5.07 “Effective Time” Section 2.01 “Employee” Section 3.01(b) “ERISA Affiliate” Section 3.10(c) “Expense Fund” Section 6.02(g) “Final Allocation Schedule” Section 2.07(e) “Financial Statements” Section 3.05(a)(i) “Holders’ Representative” Preamble BIP Investor Member Preamble Blocker Seller “Interim Balance Sheet” Section 6.7 Board Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(e) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO Section 2.14(b) NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.13.05(a)(i)
Appears in 1 contract
Sources: Merger Agreement (DarioHealth Corp.)
Terms Defined Elsewhere in this Agreement. As used The following terms are defined in this Agreement as follows: "2011 Performance Target" Section 8.25(a) "2011 Share Adjustment" Section 8.26(a) "2012 Performance Target" Section 8.25(b) "2012 Share Adjustment" Section 8.26(b) "2013 Performance Target" Section 8.25(c) "2013 Share Adjustment" Section 8.26(c) "8-K Filing" Section 8.11 "Actual Profit Notice" Section 8.26(g) "Adjustment Notice" Section 8.26(g) "Agreement, the following terms shall have the meanings ascribed to them in the sections indicated: AAA " Preamble "BVI SPV" Recitals "Company Warranties" Section 13.13(a) Affiliate Agreement Default 6.1 "Company" Preamble "Confidential Information" Section 2.14(c) Affiliate Agreement Default Notice Section 2.14(c) Affiliate Agreements Section 2.14(a) Agreement Preamble BIP Investor Member Preamble Blocker Seller Section 6.7 Board 7.1 "Consideration" Section 2.1 Board Observer "DTC" Section 2.13 Call Consummation Period 8.24 "Fees and Expenses" Section 5.1(e9.1 "Harbin Co" Recitals "Harbin Research Center" Recitals "Harbin Testing" Recitals "Heilongjiang Co" Recitals "HK SPV" Recitals "Indemnified Party" Section 10.1 "Indemnifying Party" Section 10.1 "Investor" Preamble "Investor Warranties" Section 6.2 "Issuance Notice Period" Section 8.16(c) Call Exercise Price "Key Holder" Section 5.1(e10.2(b) Call Notice "Key Holder Warranties" Section 5.1(e) Call Right 6.3 "Losses" Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period 10.1 "Material Contracts" Schedule 2 MOIC Return Threshold "▇▇. ▇▇▇" Preamble "New York Co" Recitals "Performance Targets" Section 6.5(h8.24 "PRC Opco" Recitals "Preemptive Right" Section 8.16(a) NIPSCO "Proceeds" Section 2.14(b) NiSource Directors 2.3 "Process Agent" Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.114.3
Appears in 1 contract
Sources: Securities Purchase Agreement (China XD Plastics Co LTD)
Terms Defined Elsewhere in this Agreement. As used The following terms are defined in this Agreement, the following terms shall have the meanings ascribed to them in the sections indicatedAgreement as follows: AAA Term Location Page 2010 Actual EBITDA Section 13.13(a4.9(a) Affiliate Agreement Default 29 2010 Additional Shares Section 2.14(c4.9(a) Affiliate Agreement Default Notice 29 2010 Target EBITDA Section 2.14(c4.9(a) Affiliate Agreements 29 2011 Actual EBITDA Section 2.14(a4.9(b) 30 2011 Additional Shares Section 4.9(b) 30 2011 Target EBITDA Section 4.9(b) 30 Action Section 3.2(k) 16 Agreement Preamble BIP Investor Member 1 Certificate of Designation Preamble Blocker Seller 1 Closing Date Section 6.7 Board 2.2 10 Closing Section 2.2 10 Code Section 3.2(gg)(ii) 23 Common Shares Preamble 1 Common Shares Purchase Price Section 2.1 Board Observer 10 Company Preamble 1 Consenting Parties Section 2.13 Call Consummation 3.2(e) 13 Customers Section 3.2(p)(i) 19 DOJ Section 4.4 28 Escrow Agent Section 2.3 10 Evaluation Date Section 3.2(hh) 26 Executive Shareholder Preamble 1 Expenses Section 6.2 39 FTC Section 4.4 28 Group Property Section 3.2(n) 19 Incentive Plan Section 4.10 31 Incentives Section 3.2(gg)(iv) 24 Indemnifiable Losses Section 4.12(b) 33 Indemnified Party Section 4.12(b) 33 Indemnifying Party Section 4.12(b) 33 Investment Company Act Section 3.2(ff) 23 Investor Preamble 1 Latest Closing Date Section 5.1(d) 36 Material Contracts Section 3.2(ll) 27 Overlap Period Section 5.1(e4.12(i) Call Exercise 35 Performance Milestones Section 4.10 31 Pre-Closing Period Section 3.2(gg)(i) 23 Preferred Shares Purchase Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors 2.1 10 Purchase Price Section 2.1 Drag-Along Buyer 10 Purchased Common Shares Preamble 1 Purchased Preferred Shares Preamble 1 Purchased Shares Preamble 1 Qualified Capital Market Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members 4.8 29 Redeemable Convertible Preferred Shares Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO Section 2.14(b) NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall 1 Redemption Amount Section 5.1(g4.11 32 Regulation D Preamble 1 Related Parties Section 3.2(p)(iii) Non-Transferring Member 20 Remuneration Committee Section 6.3(a4.10 31 SAFE Release Section 4.11 32 SEC Documents Section 3.2(d) Over-Contributing Member 12 Securities Act Preamble 1 Social Insurance Funds Section 5.1(b)(i3.2(s) Parent Preamble Partnership Representative 20 Tax Indemnified Party Section 10.2 Party Preamble Preemptive Right 4.12(c) 33 Waiver Section 7.1 Preemptive Right Notice Period Section 7.15.1(d) 36
Appears in 1 contract
Sources: Stock Subscription Agreement (OEP CHME Holdings, LLC)
Terms Defined Elsewhere in this Agreement. As used in this Agreement, the following terms shall have the meanings ascribed to them in the sections indicated: AAA Section 13.13(a) Affiliate Agreement Default Section 2.14(c) Affiliate Agreement Default Notice Section 2.14(c) Affiliate Agreements Section 2.14(a) Agreement Preamble BIP Investor Member Preamble BIP Investor Initial Contribution Recitals Blocker Seller Section 6.7 Board Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(e) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 GenCo Recitals GenCo Offtake Agreement Section 1.3(iv) Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Initial Contribution Recitals Investor Members Preamble Investor Return Thresholds Offer Section 6.5(h6.3(a)(i)(B) Investor Sale Notice Section 6.3(a)(i)(A) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Management Update Meeting Section 6.5(h2.7(b) NIPSCO Section 2.14(b) NHII Recitals NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Sale Notice Section 2.14(b) NiSource Shortfall Amount Section 5.1(g6.3(a)(i)(B) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.1
Appears in 1 contract
Sources: Limited Liability Company Agreement (Nisource Inc.)
Terms Defined Elsewhere in this Agreement. As used The following terms are defined in this Agreement, the following terms shall have the meanings ascribed to them in the sections indicatedAgreement as follows: AAA Additional New Models Section 13.13(a) Affiliate Agreement Default 6.02 Additional Number Section 2.14(c) Affiliate Agreement Default Notice Section 2.14(c) Affiliate Agreements Section 2.14(a10.03(b) Agreement Preamble BIP Investor Member Preamble Blocker Seller Business Section 6.7 Board Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(e) Call Exercise Price Section 5.1(e) 2.04 Call Notice Section 5.1(e) 6.06 Call Period Section 6.06 Call Purchase Price Section 6.06 Call Right Section 5.1(e6.06 Capital Contribution Section 3.01 Catch-up Amount Section 12.01(b) Capital Request Funding Date CEO Section 5.1(a5.01(a) Capital Request Notice CFO Section 5.1(a5.01(a) Company Preamble Company Business Compliance Program Section 1.3(a6.04(b) Confidential Information Section 9.6(a14.09(c) Contributing Member Conversion Section 5.1(b)(ii4.11(a) Contribution Unfunded Amount Notice COO Section 5.1(b) Corporate Opportunity Section 9.3(b5.01(a) Cure Period Section 5.1(e4.11(a) Defaulting Member Party Section 4.2 Designated Alternate 11.01 Dispute Section 2.2(e14.04(a) Directors Entitlement Section 2.1 Drag-Along Buyer 3.03 F&F Preamble First Installment Section 6.5(a3.02(a) Drag-Along First Participation Notice Section 6.5(b10.03(a) DragForm 8832 Section 7.04(a) Fund Establishment Statement Section 4.11(a) HKIAC Rules Section 14.04(c) Initial Deposit Section 3.02(a) In-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Kind Contribution Section 5.1(b)(i3.01 Installment Contribution Section 3.02(c) Fund Indemnitees Installment Contributions Section 11.7 Fund Indemnitors 3.02(c) JV Recitals License Negotiation Period Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) 6.02 Lock-Up Period Section 6.1(b8.01(a) Mandatory Capital Material Breach Section 11.01 Milestone Events Section 3.02(c) Missed Contribution Date Section 5.1(a4.11(a) Measurement New Model Section 6.02 New Model Negotiation Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO 6.02 New Model ROFR Section 2.14(b) NiSource Directors 6.02 New Model ROFR Period Section 2.2(d) NiSource Member Preamble NiSource Notes 6.02 New Securities Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) 10.02 Non-Transferring Member Defaulting Party Section 6.3(a11.01 Offer Price Section 9.01(b)(i) Over-Contributing Member Offered Securities Section 5.1(b)(i9.01(a) Parent Offered Shares Section 6.06 Offering Notice Section 9.01(a) Oversubscription Participants Section 10.03(b) Parties Preamble Partnership Representative Section 10.2 Party Preamble Permitted Transfer Section 8.02 Permitted Transferee Section 8.02(a) Preemptive Pro Rata Share Section 10.01 Preemptive Right Section 7.1 10.01 Preemptive Right Notice Rights Holder Section 10.01 Preference Amount Section 12.01(a) Reserves Section 6.03(a) Rightholder Section 9.01(a) Rightholder Option Period Section 7.19.01(b)(i) ROFO Section 9.01(b)(i) ROFO Acceptance Period Section 9.01(b)(ii) ROFO Negotiation Section 9.01(b)(ii) ROFO Participating Rightholder Section 9.01(b)(i) ROFO Participation Notice Section 9.01(b)(i) ROFO Purchaser Section 9.01(b)(ii) ROFO Sale Section 9.01(b)(ii) ROFO Sale Terms Section 9.01(b)(ii) Second Installment Section 3.02(b) Second Installment Milestone Event Section 3.02(b) Second Participation Notice Section 10.03(b) Second Participation Period Section 10.03(b) Selling Shareholder Section 9.01(a) Senior Management Personnel Section 5.01(a) Share Cancellation Section 4.11(a) Shareholder Reserved Matter Section 4.08(a) Smart King IPO Section 6.06 Tag Notice Section 9.02(c) Tag Sale Section 9.02(c) Tag-Along Right Section 9.02(a) Tag-Along Shares Section 9.02(a) Tax Partnership Election Section 7.04(a) The9 Preamble Third Installment Section 3.02(c) Third Installment Milestone Event Section 3.02(c) Third Party Purchaser Section 9.01(b)(iii) Unwinding Event Section 8.03(b) VP (IoV) Section 5.01(a) VP (R&D) Section 5.01(a) VP (Sales and Marketing) Section 5.01(a) WFOE Recitals
Appears in 1 contract
Sources: Joint Venture Agreement (The9 LTD)
Terms Defined Elsewhere in this Agreement. As used The following terms are defined in this Agreement, the following terms shall have the meanings ascribed to them in the sections indicatedAgreement as follows: AAA Section 13.13(a) Affiliate Agreement Default Section 2.14(c) Affiliate Agreement Default Acceptance Notice Section 2.14(c5.04(d) Affiliate Agreements Additional Investor Rights Section 2.14(a3.13(c) Additional Number Section 6.03(b) Agreement Preamble BIP Investor Member Preamble Blocker Seller Circular 37 Section 6.7 Board 3.04(a) Commission Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(e) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a7.02(f) Company Preamble Company Business Security Holder Section 1.3(a3.04(a) Confidential Information Controlled Entity Section 9.6(a3.04(b) Contributing Member Conversion Section 5.1(b)(ii3.13(b) Contribution Unfunded Amount Conversion Ordinary Shareholder Section 3.13(b) Conversion Preferred Shareholder Section 3.13(a) Conversion Shareholder Section 3.13(b) Covenantors Section 3.03(a) Daojia Preamble Daojia Convertible Ordinary Shares Section 3.13(b) Daojia Convertible Preferred Shares Section 3.13(a) Daojia Convertible Shares Section 3.13(b) Daojia Director Section 2.02(b)(i) Dispute Schedule 7 Exchange Act Section 7.02(i) Existing Investment Section 3.01(c) First Participation Notice Section 5.1(b6.03(a) Corporate Opportunity Section 9.3(b) Cure First Participation Period Section 5.1(e6.03(a) Defaulting Member First Refusal Right Section 4.2 Designated Alternate 5.04(a) Form F-3/S-3 Section 2.2(e7.02(e) Directors Grantee Section 2.1 Drag3.05 Granting Shareholders Section 3.05 HKIAC Section 10.04(b) Holder Section 7.02(d) Indemnification Agreement Section 2.06 Indemnification Agreements Section 2.06 Initiating Holders Section 7.03(b) Investors Preamble Issuance Period Section 6.03(e) Issuance Securities Section 6.01(a) Joinder Agreement Schedule 7 Joining Party Schedule 7 Major Subsidiaries Preamble Major Subsidiary Preamble Management Holding Entity Section 5.02(b) Media Global Director Section 2.02(b)(ii) Non-Along Buyer Compete Persons Section 6.5(a3.01(b) DragObserver Section 2.02(h) Offer Period Section 5.04(d) Offer Price Section 5.04(b) Offered Shares Section 5.04(b) Offerees Section 5.04(b) Ordinary Share Conversion Section 3.13(b) Oversubscription Participants Section 6.03(b) Participation Period Section 6.03(c) Parties Preamble Partnership Election Section 3.15(a) Party Preamble PRC Resident Enterprise Section 3.16(a) Preemptive Offer Section 6.02(b) Preemptive Offer Notice Section 6.02(a) Preemptive Right Section 6.01(a) Preemptive Right Holder Section 6.01(a) Preemptive Right Holders Section 6.01(a) Preferred Share Conversion Section 3.13(a) Pro Rata Share Section 6.01(b) Proposed Issuance Section 6.02(a) Proposed Recipient Section 6.01(a) Redemption Total Amount Section 8.01(h) register Section 7.02(a) registered Section 7.02(a) Registrable Securities Section 7.02(b) registration Section 7.02(a) Registration Expenses Section 7.02(g) Relevant Person Section 3.13(c) Remaining Shares Section 5.04(e) Request Notice Section 7.03(a) Requisite Holders Section 2.07 Restricted Shareholder Section 5.01 ROFR Right Holders Section 5.04(a) RSU Award Agreements Section 2.08 SAFE Section 3.04 SEC Section 7.02(f) Second Participation Notice Section 6.03(b) Second Participation Period Section 6.03(b) Selling Expenses Section 7.02(h) Sequoia Director Section 2.02(b)(iii) Series A Company Redemption Notice Section 8.01(e) Series A Holder Preamble Series A Holders Preamble Series A Preferred Liquidation Preference Section 9.01(c) Series A Redemption Notice Section 8.01(e) Series A Redemption Price Section 8.01(f) Series B Holder Preamble Series B Holders Preamble Series B Preferred Liquidation Preference Section 9.01(b) Series B Redemption Notice Section 8.01(c) Series B Redemption Price Section 8.01(d) Share Purchase Agreement Recitals Shareholders Agreement Schedule 7 Shareholders Meeting Section 2.01 Shelf Takedown Section 7.05(b) Special Warrant Section 5.04(g) Spousal Equivalent Section 1.01 Tag-Along Notice Section 6.5(b5.05(a)(ii) DragTag-Along Offeree Section 5.05(a)(ii) Tag-Along Pro Rata Portion Section 5.05(a)(i) Tag-Along Right Section 6.5(a5.05(a)(i) Drag-Along Sale Transfer Notice Section 6.5(a5.04(b) Event of Default Transferee Section 4.1 Event of Dissolution 5.04(b) Transferring Shareholder Section 4.3(a5.04(b) Excess Contribution U.S. Shareholders Section 5.1(b)(i3.15(c) Fund Indemnitees Violation Section 11.7 Fund Indemnitors 7.09(a) Warrant Holder Preamble Warrant Holders Preamble WFOEs Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO Section 2.14(b) NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.13.04(b)
Appears in 1 contract
Sources: Shareholder Agreement (Daojia LTD)
Terms Defined Elsewhere in this Agreement. As used in For purposes of this Agreement, the following terms shall have the meanings ascribed to them set forth in the sections indicated: AAA 3i Convertible Note Section 13.13(a9.18(gg) 401(k) Plan Section 6.17 ACA Section 4.14(b) Affiliate Agreement Default Section 3.2(b) Aggregate Valuation Section 2.14(c) Affiliate Agreement Default Notice Section 2.14(c) Affiliate Agreements Section 2.14(a2.1(c)(i) Agreement Preamble BIP Investor Member Preamble Blocker Seller Section 6.7 Board Section 2.1 Board Observer Section 2.13 Call Consummation Period Section 5.1(eAlternative Acquisition Agreement Section 6.1(b)(ii) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Date Section 5.1(a) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Section 9.3(b) Cure Period Section 5.1(e) Defaulting Member Section 4.2 Designated Alternate Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Anticipated Closing Date Section 6.16(a) Antitrust Laws Section 6.5(c) Bankruptcy and Equity Exception Section 3.4(a) Business Day Section 1.2 Certificate of Merger Section 1.1 Certificates Section 2.2(a) Charter Amendment Proposal Recitals Investor Directors Closing Section 1.2 Closing Date Section 1.2 Code Recitals Concurrent Financing Recitals Confidentiality Agreement Section 5.3 DGCL Recitals Draft Exchange Ratio Schedule Section 6.16(a) Effective Time Section 1.1 Equity Incentive Plan Amendment Proposal Recitals Exchange Act Section 3.4(c) Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.2(b) Investor Members FDA Section 3.16(a) Final Exchange Ratio Schedule Section 6.16(b) Financial Statements Section 3.5(a) GAAP Section 3.5(a) Governmental Entity Section 3.4(c) IND Section 3.16(a) Indemnified Persons Section 6.9(a) Intended Tax Treatment Recitals IRS Section 2.2(f) Liens Section 3.4(b) Ligand Preamble Investor Return Thresholds Section 6.5(h) Ligand Insurance Policies Section 3.18 Lock-Up Period Agreements Recitals Merger Recitals Merger Partner Preamble Merger Partner Allocation Percentage Section 2.1(c)(ii) Merger Partner Authorizations Section 3.16(b) Merger Partner Board Recitals Merger Partner Board Recommendation Change Section 6.1(b)(i) Merger Partner Capital Stock Recitals Merger Partner Disclosure Schedule Article III Merger Partner Leases Section 3.9(b) Merger Partner Merger Shares Section 2.1(c)(iii) Merger Partner Outstanding Shares Section 2.1(c)(iv) Merger Partner Stockholder Approval Section 3.4(a) Merger Partner Stockholder Proposal Section 3.4(a) Merger Partner Valuation Section 2.1(c)(v) Merger Partner Written Consent Section 3.4(d) Merger Sub Preamble Most Recent Balance Sheet Section 3.5(a) Most Recent Balance Sheet Date Section 3.5(a) NRS Recitals NYSE American Section 2.2(b) NYSE American Listing Application Section 4.4(c) Opinion of Financial Advisor Section 4.19 Other Public Company Stockholder Proposal Section 3.5(b) Outside Date Section 8.1(b) Permits Section 3.16(a) Post-Closing Public Company Shares Section 2.1(c)(vi) Public Company Preamble Public Company Allocation Percentage Section 2.1(c)(vii) Public Company Authorizations Section 4.16(a) Public Company Balance Sheet Section 4.5(b) Public Company Board Recitals Public Company Board Recommendation Change Section 6.1(b)(i) Public Company Closing Price Section 2.1(c)(viii) Public Company Contingent Workers Section 4.17(b) Public Company Disclosure Schedule Article IV Public Company EIP Section 4.2(b) Public Company Equity Awards Section 4.2(b) Public Company Financial Advisor Section 4.19 Public Company Insurance Policies Section 4.18 Public Company Leases Section 4.9(b) Public Company Outstanding Shares Section 2.1(c)(ix) Public Company Preferred Stock Section 4.2(a) Public Company RSU Award Section 4.2(b) Public Company SEC Reports Section 4.5(a) Public Company Series A Preferred Stock Recitals Public Company Stock Option Section 4.2(b) Public Company Stock Plans Section 4.2(b) Public Company Valuation Section 2.1(c)(x) Public Company Warrants Section 4.2(c) Public Company Written Consent Section 4.4(d) Recommendation Change Notice Section 6.1(b) Mandatory Capital Contribution Regulating Authorities Section 5.1(a 3.16(a) Measurement Period Schedule 2 MOIC Return Threshold Representatives Section 6.5(h 6.1(a) NIPSCO Required Public Company Stockholder Approvals Section 2.14(b 3.5(b) NiSource Directors Required Public Company Stockholder Proposals Section 2.2(d 3.5(b) NiSource Member Preamble NiSource Notes Rule 145 Affiliates Section 2.14(b6.8 SEC Section 3.4(c) NiSource Shortfall Amount Securities Act Section 5.1(g3.2(b) Non-Transferring Member Security Holder Litigation Section 6.3(a6.14 Share Issuances Recitals Securities Purchase Agreement Recitals Surviving Corporation Section 1.3 Treasury Stock Method Section 2.1(c)(xi) Over-Contributing Member WARN Act Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.13.17(e)
Appears in 1 contract
Sources: Agreement and Plan of Merger (Channel Therapeutics Corp)
Terms Defined Elsewhere in this Agreement. As used in For purposes of this Agreement, the following terms shall have the meanings ascribed to them set forth in the sections Sections indicated: AAA 280G Stockholder Approval Section 13.13(a5.16 Aggregate ARS Face Value Section 2.8(b) Affiliate Aggregate ARS Market Value Section 2.8(b) Agreement Default PREAMBLE Appraisal Shares Section 2.14(c2.7(g) Affiliate Assumptions Section 3.23 Bank PREAMBLE Cancelled Escrowed Earnout Shares Section 2.8(b) Certificate of Merger Section 2.3 Change of Control Section 5.19(a) Claimant Section 11.13(c)(ii) Closing Section 2.2 Closing Date Section 2.2 Code RECITALS Company PREAMBLE Company Board Recommendation Section 3.24(a) Company Certificates Section 2.7(d) Company Common Stock Section 2.7(b) Company Constituent Documents Section 3.3 Company Cure Period Section 9.1(f)(ii) Company Disclosure Schedule Update Section 5.8(b) Company Common Stock Section 2.7(b) Company Financial Statements Section 3.5(a)(i) Company Financial Projections Section 3.23 Company Interim Balance Sheet Section 3.5(a)(ii) Company Option Section 2.7(f) Company Options Section 2.7(f) Company Purchase Commitments Section 3.22 Company Real Property Leases Section 3.9(c) Company Registered Proprietary Asset Section 3.10(a)(ii) Company Returns Section 3.15(a) Company Sale Section 5.19(a) Company Software Products Section 3.10(a)(i) Company Stockholder Representation Letters Section 5.12 Company Stockholders Approval Section 3.24(b) Company Stockholders Meeting Section 3.24(a) Confidentiality Agreement Default Section 5.4 Continuing Employees Section 5.15(a) Converted Option Section 2.7(f) Converted Option Shares Section 2.7(f) Demand Section 11.13(c)(ii) DGCL RECITALS DLLCA RECITALS Disputes Section 11.13(c) Distribution Percentage of Escrowed Earnout Shares Section 2.8(b) DOJ Section 5.18 Duff & ▇▇▇▇▇▇ Opinion Section 7.6(f) Earnout Calculation Date Section 2.8(b) Earnout Calculation Table Section 2.8(b) Earnout Distribution Date Section 2.8(b) Earnout Options Section 2.7(f) Effective Time Section 2.3 Employment Agreements Section 7.6(h) Escrow Agent Section 2.8(a) Escrow Agreement Section 2.8(a) Escrowed Earnout Shares Section 2.7(c) Exchange Agent Section 2.9(a) Exchange Fund Section 2.9(a) Exchange Ratio Section 2.7(c) Federal Reserve Section 3.21(c) General Partner RECITALS Limited Partners RECITALS Lock-Up Agreements RECITALS Lock-Up Stockholders RECITALS Material Contract Section 3.11(a) Merger RECITALS Merger Sub PREAMBLE Negotiation Period Section 5.19(b) Offer Exercise Notice Section 2.14(c5.19(b) Affiliate Agreements Offer Period Section 2.14(a5.19(b) Open Period Section 5.19(c) Parent PREAMBLE Parent Benefit Plans Section 5.15(a) Parent Bylaws Section 4.3 Parent Charter Section 4.3 Parent Common Stock Section 2.7(a) Parent Company Section 4.1(a) Parent Constituent Documents Section 4.3 Parent Cure Period Section 9.1(g)(ii) Parent Disclosure Schedule Update Section 5.8(c) Parent Financial Advisor Section 4.19 Parent Financial Statements Section 4.5(a) Parent Interim Balance Sheet Section 4.5(a)(ii) Parent Options Section 4.4(a) Parent Material Contract Section 4.8(a) Parent Qualified Plan Section 4.13(f) Parent Reports Section 4.20(a) Parent Returns Section 4.12(a) Partnership RECITALS PCEquity RECITALS Permissible Activities Section 3.31 Permissible Assets Section 3.31 Pre-Closing Period Section 5.1 Proxy Statement Section 5.3(a) Qualified Plan Section 3.16(j) Registration Rights Agreement Preamble BIP Investor Member Preamble Blocker Seller Section 6.7 Board 7.6(c) Registration Statement Section 5.21 Regulatory Approvals Section 3.21(c) Related Party Section 3.19(f) Required Approvals Section 5.13(a) Respondent Section 11.13(c)(ii) Restraint Section 6.2 Sale Notice Section 5.19(b) SEC Order 0 Section 262 Section 2.7(c) Section 280G Payments Section 5.16 SRO Section 3.21(c) Stock Purchase Agreement RECITALS Surrender Date Section 2.9(b) Surviving LLC Section 2.1 Board Observer Target Companies Section 2.13 Call Consummation Period 3.1(a) Target Company Section 5.1(e3.1(a) Call Exercise Price Section 5.1(e) Call Notice Section 5.1(e) Call Right Section 5.1(e) Capital Request Funding Termination Date Section 5.1(a9.1(b) Capital Request Notice Section 5.1(a) Company Preamble Company Business Section 1.3(a) Confidential Information Section 9.6(a) Contributing Member Section 5.1(b)(ii) Contribution Unfunded Amount Notice Section 5.1(b) Corporate Opportunity Termination Fee Section 9.3(b) Cure Period Termination Expenses Section 5.1(e9.3(b) Defaulting Member Third Party Proprietary Asset Section 4.2 Designated Alternate 3.10(d) Transaction Shares Section 2.2(e) Directors Section 2.1 Drag-Along Buyer Section 6.5(a) Drag-Along Notice Section 6.5(b) Drag-Along Right Section 6.5(a) Drag-Along Sale Section 6.5(a) Event of Default Section 4.1 Event of Dissolution Section 4.3(a) Excess Contribution Section 5.1(b)(i) Fund Indemnitees Section 11.7 Fund Indemnitors Section 11.7 Independent Evaluator Section 13.15 Investment Closing Date Recitals Investor Directors Section 2.2(b) Investor Members Preamble Investor Return Thresholds Section 6.5(h) Lock-Up Period Section 6.1(b) Mandatory Capital Contribution Section 5.1(a) Measurement Period Schedule 2 MOIC Return Threshold Section 6.5(h) NIPSCO Section 2.14(b) NiSource Directors Section 2.2(d) NiSource Member Preamble NiSource Notes Section 2.14(b) NiSource Shortfall Amount Section 5.1(g) Non-Transferring Member Section 6.3(a) Over-Contributing Member Section 5.1(b)(i) Parent Preamble Partnership Representative Section 10.2 Party Preamble Preemptive Right Section 7.1 Preemptive Right Notice Period Section 7.12.7(c)
Appears in 1 contract